Hepatocellular carcinoma (HCC) is a lethal malignancy with a lack of effective treatments particularly for the disease at an advanced stage. Even though immune checkpoint inhibitors (ICIs) have made great progress in the treatment of HCC. durable and ideal clinical benefits still cannot be achieved in plenty of patients with HCC. Therefore. https://www.remtavares.com/